Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 128

1 1 Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27(3):315–389.

2 2 Lazarus JH, Brown RS, Daumerie C, Hubalewska‐Dydejczyk A, Negro R, Vaidya B. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children. Eur Thyroid J. 2014; 3(2):76–94.

3 3 Okosieme OE, Marx H, Lazarus JH. Medical management of thyroid dysfunction in pregnancy and the postpartum. Expert OpinPharmacother. 2008; 9(13):2281–2293.

4 4 Andersson M, de BB, Delange F, Zupan J. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2‐years‐old: conclusions and recommendations of the Technical Consultation. Public Health Nutr. 2007; 10(12A):1606–1611.

5 5 Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002; 12(1):63–68.

6 6 Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, Cunningham FG. Subclinical hypothyroidism and pregnancy outcomes. Obstetrics and Gynecology. 2005; 105(2):239–245.

7 7 Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. NEnglJMed. 1999; 341(8):549–555.

8 8 Chan S, Franklyn JA, Kilby MD. Maternal thyroid hormones and fetal brain development. Current Opinion in Diabetes and Endocrinology. 2005; 12(1):23–30.

9 9 Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, Chiusano E, John R, Guaraldo V, George LM, Perona M, Dall'Amico D, Parkes AB, Joomun M, Wald NJ. Antenatal thyroid screening and childhood cognitive function. NEnglJMed. 2012; 366(6):493–501.

10 10 Casey BM, Thom EA, Peaceman AM, Varner MW, Sorokin Y, Hirtz DG, Reddy UM, Wapner RJ, Thorp JM, Jr., Saade G, Tita AT, Rouse DJ, Sibai B, Iams JD, Mercer BM, Tolosa J, Caritis SN, VanDorsten JP, Eunice Kennedy Shriver National Institute of Child H, Human Development Maternal‐Fetal Medicine Units N. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy. The New England journal of medicine. 2017; 376(9):815–825.

11 11 Velkeniers B, Van MA, Poppe K, Unuane D, Tournaye H, Haentjens P. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta‐analysis of RCTs. HumReprodUpdate. 2013; 19(3):251–258.

12 12 Dhillon‐Smith RK, Middleton LJ, Sunner KK, Cheed V, Baker K, Farrell‐Carver S, Bender‐Atik R, Agrawal R, Bhatia K, Edi‐Osagie E, Ghobara T, Gupta P, Jurkovic D, Khalaf Y, MacLean M, McCabe C, Mulbagal K, Nunes N, Overton C, Quenby S, Rai R, Raine‐Fenning N, Robinson L, Ross J, Sizer A, Small R, Tan A, Underwood M, Kilby MD, Boelaert K, Daniels J, Thangaratinam S, Chan SY, Coomarasamy A. Levothyroxine to increase live births in euthyroid women with thyroid antibodies trying to conceive: the TABLET RCT. Southampton (UK) 2019.

13 13 Clementi M, Di GE, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: delineation of the phenotype. AmJ Med Genet. 1999; 83(1):43–46.

14 14 Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. The Journal of clinical endocrinology and metabolism. 2013; 98(11):4373–4381.

15 15 Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J ClinEndocrinol Metab. 1997; 82(11):3633–3636.

16 16 Eisenstein Z, Weiss M, Katz Y, Bank H. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. EurJ Pediatr. 1992; 151(8):558–559.

17 17 Krassas GE, Poppe K, Glinoer D. Thyroid Function and Human Reproductive Health. EndocrRev. 2010; 31(5):702–755.

18 18 Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. ObstetGynecol. 2006; 107(2 Pt 1):337–341.

19 19 Association of Clinical B, British Thyroid A, British Thyroid F. UK guidelines for the use of thyroid function tests (http://www.acb.org.uk/docs/TFTguidelinefinal.pdf) 2006:39–43.

20 20 Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH‐receptor antibody measurements in pregnancy: results of an evidence‐based symposium organized by the European Thyroid Association. EurJ Endocrinol. 1998; 139(6):584–586.

21 21 LaFranchi SH, Haddow JE, Hollowell JG. Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? Thyroid. 2005; 15(1):60–71.

22 22 Mestman JH. Hyperthyroidism in pregnancy. Best PractResClinEndocrinol Metab. 2004; 18(2):267–288.